1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Shofu Inc.

Shofu Inc.

7979.T
Shofu Inc.JP flagTokyo Stock Exchange
2,054.00
JPY
-39.00
- -
73.10BMarket Cap
Shofu Inc.
7979.T
(Tokyo Stock Exchange)

Recent

price

2,054.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
488.74
497.26
499.88
572.89
617.18
719.09
701.15
755.93
783.44
819.36
709.85
791.25
889.57
989.19
1,089.19
1,124.18
525.05
Revenue per Share
14.15
15.87
0.56
15.88
18.21
24.69
26.28
27.59
37.76
22.09
48.15
71.6
88.04
103.06
121.51
137.37
59.06
Basic EPS, GAAP
20.5
27.81
-25.64
3.89
-41.66
27.61
45.11
38.75
4.06
12.33
49.61
75.11
43.19
38.86
59.95
-6.49
- -
Free Cash Flow per Basic Share
8.99
8.99
10.01
9.48
9
8.98
8.99
9.97
10
12.46
11.42
16.99
20.5
30.96
38.98
51.97
- -
Dividend per Share
436.35
443.23
435.66
444.65
456.93
471.8
350.5
509
536.54
543.37
577.66
617.8
684.46
759.43
840.55
924.87
804.53
Book Value per Share
546.2
556.4
576.82
614.56
675.61
617.78
652.52
719.57
731.05
741.43
858.72
914.26
984.28
1,158.49
1,187.11
1,351.14
1,156.53
Tangible Book Value per Share
32
32
32
32
32
32
32
32
32
32
35
36
36
35
36
36
35
Basic Weighted Avg Shares
15,711
15,985
16,028
18,258
19,688
22,975
22,305
24,031
24,915
26,108
24,680
28,137
31,678
35,080
38,698
39,994
18,633
Sales/Revenue/Turnover
6.01
6.24
4.53
5.41
5.9
6.83
6.2
6.23
7.28
8.47
9.32
11.43
12.07
13.42
13.93
13.07
13.71
Operating Margin (%)
702
712
660
656
783
1,063
938
974
893
978
955
901
971
1,168
1,059
1,210
- -
Depreciation Expense
455
510
18
506
581
789
836
877
1,201
704
1,674
2,546
3,135
3,655
4,317
4,887
2,096
Net Income, GAAP
40.6
46.88
94.94
48.26
40.1
41.2
26.21
35.22
29.96
38.85
28.35
28.88
28.34
30.37
29.56
25.71
27.32
Effective Tax Rate (%)
2.9
3.19
0.11
2.77
2.95
3.43
3.75
3.65
4.82
2.7
6.78
9.05
9.9
10.42
11.16
12.22
11.25
Profit Margin (%)
10,244
10,722
9,996
10,497
10,115
11,216
11,071
11,682
11,155
11,736
13,617
16,025
16,271
19,586
22,303
23,550
21,073
Working Capital
- -
- -
- -
- -
111
1,729
1,225
986
125
678
1,190
1,153
281
- -
- -
- -
- -
LT Debt
18,233
18,439
18,662
19,747
21,781
21,500
22,296
24,154
24,381
23,935
30,196
32,938
35,513
41,608
42,733
48,687
41,603
Total Equity
2.89
2.71
0.19
2.56
3.08
3.78
4.25
3.84
4.91
5.31
5.7
6.77
7.56
8.17
8.79
8.31
4.5
Return on Invested Capital (%)
3.11
3.42
0.13
3.51
3.68
4.56
5.58
5.77
6.78
3.78
8.18
11.13
12.71
13.79
15.07
15.54
7.69
Return on Capital (%)
3.26
3.61
0.13
3.6
4.04
5.32
6.38
6.42
7.23
4.1
8.95
12.11
13.53
14.25
15.2
15.57
7.8
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
281
- -
200
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
- -
36
Market Capitalization
52,017
83,042
82,403

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
25,179
- -
26,226
Cash, Cash Equivalents & STI
9,716
- -
9,462
Accounts Receivable, Net
4,538
- -
4,271
Inventories
10,290
- -
11,344
Total Current Liabilities
5,593
- -
5,153
Payables & Accruals
- -
- -
- -
ST Debt
281
- -
200
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.8%
10.14%
13.93%
Free Cash Flow
44.83%
-10.85%
-110.85%
Net Income, GAAP
26.73%
24.62%
13.2%
Sales/Revenue/Turnover
5.88%
10.2%
3.35%
Total Cash Common Dividend
- -
36.61%
33.5%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8,265
8,182
8,956
9,677
35,080
2025
- -
- -
- -
- -
38,698
2026
- -
- -
- -
- -
39,994

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19.37
- -
- -
- -
103.06
2025
- -
- -
- -
- -
121.51
2026
- -
- -
- -
- -
137.37

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
30.96
2025
- -
- -
- -
- -
38.98
2026
- -
- -
- -
- -
51.97
Similar Companies
Akoya Biosciences, Inc. (AKYA)
AegirBio AB (publ) (AEGIR.ST)
Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ)
Straumann Holding AG (SAUHY)
OrbusNeich Medical Group Holdings Limited (6929.HK)
AddLife AB (publ) (ADDLF)
Business
Shofu Inc. (7979.T), a Japan-based company founded in 1922 and headquartered in Kyoto, manufactures and sells dental materials and equipment worldwide, operating primarily in the dental segment alongside smaller nail care and industrial materials businesses; its core products encompass abrasives, diamonds and carbides, cements, preventives, restoratives including bioactive composites, packable and flowable composites, glass ionomers, and sealants; dental ceramics, indirect composites, porcelain systems such as Vintage PRO, Halo, ZR, and MP, artificial teeth like Veracia and Endura, CAD/CAM materials for crowns, bridges, dentures, and implants; rotary instruments, polishers including Brownie, Greenie, Supergreenie, and Ceramisté series, prosthetics, adhesives like Super-Bond, instruments, waxes, articulators, and acrylic materials, with sales and subsidiaries spanning the United States, Germany, United Kingdom, China, Singapore, Brazil, India, Taiwan, and Vietnam. The company changed its name from Shofu Dental Mfg. Co., Ltd. to Shofu Inc. in 1983 and listed on the First Section of the Tokyo Stock Exchange in 2012; recent developments include enhanced business alliances and capital participation with Mitsui Chemicals Inc. and Sun Medical Co., Ltd. in 2020, enabling initiatives such as the 2023 launch of Super-Bond dental adhesive in Brazil through a three-way partnership, alongside ongoing expansion via new subsidiaries like SHOFU Products Vietnam Co., Ltd. in 2020 and SHOFU Dental Brasil and India entities in 2017.